Therapeutic drug monitoring of voriconazole: validation of a high performance liquid chromatography method and comparison with an ARK immunoassay

High-performance liquid chromatographic method for determination of voriconazole in pure and gel formulation

For routine measurement of Voriconazole (VZ) in a pure and gel formulation, a quick and accurate RP-HPLC technique with UV detection (254 nm) was developed. With a flow rate of 1.0 ml/min using a mobile phase that contained acetonitrile and water mixed 50:50, v/v. Internal standard approach was used for quantification. The method shows good linearity (correlation coefficient = 0.9999) with acceptable accuracy, precision and robustness. Three elements were taken into account to measure robustness. Flow rate, mobile phase composition, and pH all have an impact on the response, but only the flow rate which causes a reduction in the concentration of the drug-has a significant impact on the response. Analyst, equipment, and days were taken into consideration for a precision measurement. The analytical procedure had good precision, as seen by the %RSD which is found to be less than 2.0. The proposed method was straightforward, extremely sensitive, exact, and accurate, and it had a retention time of less than 4 minutes, indicating that it is appropriate for daily quality control.

Overview of therapeutic drug monitoring and clinical practice

With the rapid development of clinical pharmacy in China, therapeutic drug monitoring (TDM) has become an essential tool for guiding rational clinical drug use and is widely concerned. TDM is a tool that combines pharmacokinetic and pharmacodynamic knowledge to optimize personalized drug therapy, which can improve treatment outcomes, reduce drug-drug toxicity, and avoid the risk of developing drug resistance. To effectively implement TDM, accurate and sophisticated analytical methods are required. By researching the literature published in recent years, we summarize the types of commonly monitored drugs, therapeutic windows, and clinical assays and track the trends and hot spots of therapeutic drug monitoring. The purpose is to provide guidelines for clinical blood drug concentration monitoring, to implement individualized drug delivery programs better, to ensure the rational use of drugs for patients, and to provide a reference for the group to carry out related topics in the future.